Mark Haddad has an extensive corporate practice for a client base that ranges from investment funds to startup and portfolio companies to large public companies. His work for them encompasses both transactional and governance issues.
Mark advises start-up companies – primarily those in the cleantech, high tech and life sciences sectors – on corporate formation, venture capital financing, and general corporate matters. He also represents private equity, venture capital and angel investors in portfolio investments with start-up and other companies.
More »
For publicly held companies such as CRA International, Inc. and ABIOMED, Inc., Mark offers guidance on general corporate matters, securities filings in compliance with the federal securities laws, and corporate finance (including public offerings and private placements). His transactional practice has particular emphasis on representing both buyers and sellers in mergers and acquisitions, joint ventures and other strategic transactions. As part of this work, he counsels public companies regarding defensive measures, including the adoption of stockholder rights plans.
